EFFECTS OF PREOPERATIVE TRANSCATHETER HEPATIC ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA - THE RELATIONSHIP BETWEEN POSTOPERATIVE COURSE AND TUMOR NECROSIS

被引:0
|
作者
ADACHI, E
MATSUMATA, T
NISHIZAKI, T
HASHIMOTO, H
TSUNEYOSHI, M
SUGIMACHI, K
机构
[1] KYUSHU UNIV,FAC MED,DEPT PATHOL 2,3-1-1 MAIDASHI,HIGASHI KU,FUKUOKA 812,JAPAN
[2] KYUSHU UNIV,FAC MED,DEPT SURG 2,FUKUOKA 812,JAPAN
关键词
PREOPERATIVE TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; HEPATOCELLULAR CARCINOMA; TUMOR NECROSIS; RECURRENCE; HEPATIC RESECTION;
D O I
10.1002/1097-0142(19931215)72:12<3593::AID-CNCR2820721208>3.0.CO;2-T
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. The effects of preoperative transcatheter arterial chemoembolization (TAE) for hepatocellular carcinoma (HCC) remain a matter of controversy. Methods. Seventy-two patients with HCC were entered in the study; the patients did not have the risk factors for disease recurrence of tumor larger than 5 cm in diameter, the presence of venous invasion, or intrahepatic metastasis. Only patients with 3 years of follow-up after curative resection were selected. Forty-six underwent TAE (Group I) and 26 did not undergo TAE (Group II). Group I was divided into three subgroups according to the degree of tumor necrosis: IA, complete necrosis; IB, partial necrosis; and IC, no necrosis. Group II was divided into two subgroups: IIB, partial necrosis; and IIC, no necrosis. Results. Preoperative TAE did not improve the average disease-free survival rates of the group as a whole. For patients undergoing TAE, the survival rate of Group IB was significantly worse than that of Groups IA or IC. The survival rate of Group IB was worse than that of Group II, but the difference was not significant. In Group II, the survival of Group IIB was worse than that of Group IIC. Histologically, residual tumor cells lacking mutual contact were detected in some patients in Group IB. Conclusion. These results indicate that partial tumor necrosis caused by preoperative TAE or spontaneous tumor necrosis per se might facilitate postoperative disease recurrence. This may occur because in patients with partial necrosis, the remaining tumor cells are less firmly attached and more likely to be dislodged into the bloodstream during hepatic resection.
引用
收藏
页码:3593 / 3598
页数:6
相关论文
共 50 条
  • [31] EXPERIENCE WITH LIVER RESECTION AFTER HEPATIC ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    YU, YQ
    XU, DB
    ZHOU, XD
    LU, JZ
    TANG, ZY
    MACK, P
    CANCER, 1993, 71 (01) : 62 - 65
  • [32] A RANDOMIZED TRIAL OF HEPATIC ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    PELLETIER, G
    ROCHE, A
    INK, O
    ANCIAUX, ML
    DERHY, S
    ROUGIER, P
    LENOIR, C
    ATTALI, P
    ETIENNE, JP
    JOURNAL OF HEPATOLOGY, 1990, 11 (02) : 181 - 184
  • [33] HEPATOCELLULAR-CARCINOMA - TREATMENT WITH A COMBINATION OF TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION AND TRANSPORTAL ETHANOL INJECTION
    YAMAKADO, K
    HIRANO, T
    KATO, N
    TAKEDA, K
    NAKAGAWA, T
    TAKASE, K
    NAKANO, T
    MURAYAMA, T
    MATSUDA, A
    RADIOLOGY, 1994, 193 (01) : 75 - 80
  • [34] MR IMAGING OF THE LIVER BEFORE AND AFTER TRANSCATHETER HEPATIC CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    YOSHIOKA, H
    NAKAGAWA, K
    SHINDOU, H
    ONO, Y
    KAWAKAMI, A
    MABUCHI, N
    ARITA, S
    FUJII, K
    HAMADA, T
    ISHIDA, O
    MIYAKOSHI, K
    UTO, T
    ACTA RADIOLOGICA, 1990, 31 (01) : 63 - 67
  • [35] EMBOLIZATION OF THE HEPATIC FALCIFORM ARTERY TO PREVENT SUPRAUMBILICAL SKIN RASH DURING TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    UENO, K
    MIYAZONO, N
    INOUE, H
    MIYAKE, S
    NISHIDA, H
    NAKAJO, M
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 18 (03) : 183 - 185
  • [36] ARTERIAL CHEMOEMBOLIZATION WITH MITOMYCIN-C MICROCAPSULES FOLLOWED BY TRANSCATHETER HEPATIC-ARTERY EMBOLIZATION FOR HEPATOCELLULAR-CARCINOMA
    OHNISHI, K
    SUGITA, S
    NOMURA, F
    IIDA, S
    TANABE, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (09): : 876 - 879
  • [37] RESULTS OF HEPATIC RESECTION AND POSTOPERATIVE ARTERIAL CHEMOTHERAPY FOR HEPATOCELLULAR-CARCINOMA
    HARADA, A
    NONAMI, T
    KISHIMOTO, W
    NAKAO, A
    TAKAGI, H
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 : S35 - S37
  • [38] Infiltrative Hepatocellular Carcinoma: Transcatheter Arterial Chemoembolization Versus Hepatic Arterial Infusion Chemotherapy
    An, Chao
    Zuo, Mengxuan
    Li, Wang
    Chen, Qifeng
    Wu, Peihong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [39] Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis
    Lei Jianyong
    Zhong Jinjing
    Wang Wentao
    Yan Lunan
    Zhou Qiao
    Li Bo
    Wen Tianfu
    Xu Minqing
    Yang Jiaying
    Wei Yongang
    ANNALS OF HEPATOLOGY, 2014, 13 (04) : 394 - 402
  • [40] Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell
    Zhang, Juqiang
    Peng, Hao
    Wang, Botian
    Luo, Lei
    Cheng, Yuan
    He, Guolin
    Tang, Yujun
    Pan, MingXin
    JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (07) : 1770 - 1778